Reporting Arava Side Effects to the FDA
MedWatch is the FDA's program that allows consumer to report serious
reactions and problems with medical products. So far, there have
been at least 130 cases of severe liver problems (hepatoxicity)
and 22 deaths since Arava's arrival to the market in 1998. It is
estimated that there is a 10-100 fold of underreporting that occurs
with a drug's adverse effects. Not reporting serious adverse Arava
side effects can result in continued instances of death and serious
health conditions that may have been prevented. If you, or a family
member, have suffered the serious and potentially deadly Arava side
effects, it is encouraged for you to report it, and there are several
different reporting options available.
Your health care provider or the FDA
online reporting form allows consumers to notify the FDA of
important and useful information regarding patient safety. The FDA's
MedWatch has outlined the injuries that constitute a serious adverse
event. If you, or a family member, have experienced any of these
adverse Arava side effects you are encouraged to report it to the
FDA. To learn your legal rights regarding Arava, contact us to receive
your free consultation with an expert Arava attorney.
Death
Report if the patient's death is suspected as being a direct outcome
of the adverse Arava event.
Life-Threatening
Report if the patient was at substantial risk of dying at the time
of the adverse Arava event or it is suspected that the use or continued
use of the product would result in the patient's death.
Hospitalization (initial or prolonged)
Report if admission to the hospital or prolongation of a hospital
stay results because of the adverse Arava event.
Disability
Report if the adverse Arava event resulted in a significant, persistent,
or permanent change, impairment, damage or disruption in the patient's
body function/structure, physical activities or quality of life.
Congenital Anomaly
Report if there are suspicions that exposure to a medical product
prior to conception or during pregnancy resulted in an adverse outcome
in the child.
Requires Intervention to Prevent Permanent Impairment or
Damage
Report if you suspect that the use of Arava may result in a condition,
which requires medical or surgical intervention to preclude permanent
impairment or damage to a patient.
top
|